Ra Medical Systems Receives FDA IDE Approval to Begin Pivotal Atherectomy Clinical Study

Stock Information for Ra Medical Systems Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Ra Medical Systems Inc.

Reminder: Ra Medical Systems Announces Name and Ticker Symbol Changes
Ra Medical Systems Announces Allowance of New Closure Device Patent
Ra Medical Systems Announces Milestone Achievement for Electrophysiology Division
Ra Medical Systems Announces Proposed Name and Ticker Symbol Changes
Ra Medical System's Electrophysiology Division Has Increased Demand for its Non-invasive Mapping System
RMED's LockeT Device Utilized in Structural Heart Procedures
RMED's Electrophysiology Division Expands International Distribution
RMED's Electrophysiology Division Submits Data for CE Mark on LockeT Expects to Receive CE Mark in Third Quarter, 2023

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.